{"disease":{"id":"rabies-post-exposure","name":"rabies post exposure"},"drugs":{"marketed":[{"drug_id":"hospital-based-vaccination-pathway","indication_name":"Rabies (post-exposure)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Hospital-Based Vaccination Pathway","generic_name":"hospital-based-vaccination-pathway","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"various pathogens","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05846568","title":"Study to Evaluate GR1801's Efficacy and Safety","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1200,"lead_sponsor_name":"Genrix (Shanghai) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07327307","title":"Real World Evidence Study of SYN023 in Children Exposed to Rabies","phase":"","overall_status":"RECRUITING","enrollment_count":232,"lead_sponsor_name":"Synermore Biologics (Suzhou) Co., Ltd.","has_results":false},{"nct_id":"NCT05684185","title":"Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Institut Pasteur du Cambodge","has_results":false},{"nct_id":"NCT07342257","title":"SYN023 With Rabies Vaccine in Healthy Pediatric Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Synermore Biologics (Suzhou) Co., Ltd.","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}